HCWB 8-K 2026-11-05

HCW Biologics Inc. (HCWB) 8-K dated 2026-11-05 — accession 0001493152-26-050082.

HCW Biologics Inc. (HCWB) is a biotechnology company listed on US.

HCW Biologics Inc. filed a 8-K on 2026-11-05. Accession 0001493152-26-050082.

This 8-K covers: Material agreement (Item 1.01), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported HCWB revenue for 2025-12-31 was $54.2K. Net income was -$8.0M. Revenue was down 97.9% from 2024-12-31 to 2025-12-31. HCWB currently screens at market cap $14.2M.

Not investment advice. The HCWB SEC hub lists recent forms. The stock page is the research view.